61. Migraine Associated Vertigo Olsson (1991) in a study of 50 patients with basilar migraine (which is rare) Neurotologic findings in basilar migraine. Laryngoscope 101141, 1991 http://www.tchain.com/otoneurology/disorders/central/migraine/mav.html

Migraine Associated Vertigo (MAV) Adapted from lecture handout given for the seminar "Recent advances in the treatment of Dizziness", American Academy of Neurology, 1997 and "Migraine Vs Meniere's", at the American Academy of Otolaryngology meeting, 1999-2001. Last edited: 2/2003 Please read our Education Index Search this site Timothy C. Hain, MD , Chicago IL. Dizziness and headache are individually very common human conditions and their combination is also a common symptom complex. Diagnostically, one must determine whether the dizziness and headaches are independent or related to each other, and in particular, whether they are a manifestation of migraine. Here we will review the association between vertigo and migraine. This subject has also been recently reviewed by Reploeg and Goebel (2002) as well as Radke et al (2002). Epidemiology Nearly 13% of the adult population of the United States has migraine. There is a male-female distribution difference. At all ages, about 5% of men have migraine (Stewart, 1994; Lipton et al, 2002). Women of childbearing age have a much higher prevalence, jumping up to roughly 10% at the onset of menstruation, and increasing to nearly 30% at the peak age of 35 years. At menopause, rates of migraine abruptly decline in women back to roughly 10%. The prevalence of Migraine is far higher than that of Meniere's disease , which occurs in only 0.2% of the US population (Wladislavosky-Waserman et al, 1984). In a small study of persons with Menieres disease, the prevalence of Migraine was about 50%, compared with a figure of about 25% in the non-Meniere's population (Radke et al, 2002). Other studies have shown different results however. There have also been recent studies showing that there is a higher frequency of

62. Discussion Forum Full Version Vertebrobasilar migraine And Triptans Discussion Forum Archivesof CHILD-NEURO@listserver.itd.umich.edu Clinical Practice http://www.child-neuro.org.uk/forums/lofiversion/index.php/t25.html

Help Search Member List Calendar Full Version: Discussion Forum Discussion Forum Child Neurology Trainees Area (1 posts) (117 posts) This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here Invision Power Services, Inc.

63. MAXALT of migraine or for use in the management of hemiplegic or basilar migraine . not be administered to patients with hemiplegic or basilar migraine. http://www.maxalt.com/rizatriptan_benzoate/maxalt/hcp/index.jsp

64. Piracetam Treatment Of Migraine Headache Vestibular disorders in patients with migraine. Szirmai A. This socalledvestibular migraine is different from basilar migraine, which involves the http://www.piracetam.com/piracetam-110.htm

Vestibular disorders in patients with migraine. Szirmai A. Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Semmelweis University Medical School, Budapest, Hungary. Eur Arch Otorhinolaryngol 1997;254 Suppl 1:S55-7 Abstract piracetam . Diazepam was used to treat basilar migraine and flunarizine to prevent vestibular migraine. Picamilon Modafinil Deprenyl CDP choline ... Order Alzheimer's piracetam Alzheimer's study piracetam controlled study with dementia syndrome piracetam induced EEG changes in Alzheimer's piracetam effect on cerebral metabolism in Alzheimer's piracetam reverses hippocampal changes in Alzheimer's piracetam use in Alzheimer's piracetam effect on senile dementia memory Alcoholism piracetam alcoholic treatment piracetam efficacy in chronic alcoholics piracetam effect on alcoholics piracetam in acute alcohol withdrawal Brain injury piracetam effect on consciousness due to head injury piracetam protection in brain injury piracetam use in severe brain injury piracetam and concussion Circulatory disorders piracetam effectiveness in cerebral arteriosclerosis piracetam and chronic cerebrovascular disorders piracetam effect on brain circulation failure Deafness piracetam use in sudden deafness piracetam sudden hearing loss treatment piracetam in tinnitus and sudden deafness piracetam treatment of sudden deafness Dyslexia piracetam verbal effect in dyslexic boys piracetam efficacy in dyslexic reading and writing disorders piracetam improves reading in

65. Piracetam Treatment Of Migraine Headache This socalled vestibular migraine is different from basilar migraine, whichinvolves the irritation of the cervical sympathetic system, and can cause http://www.piracetam.com/piracetam/piracetam-110.htm

Vestibular disorders in patients with migraine. Szirmai A. Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Semmelweis University Medical School, Budapest, Hungary. Eur Arch Otorhinolaryngol 1997;254 Suppl 1:S55-7 Abstract piracetam . Diazepam was used to treat basilar migraine and flunarizine to prevent vestibular migraine. Picamilon Modafinil Deprenyl Piracetam ... Order Alzheimer's disease piracetam and Alzheimer's piracetam therapy in Alzheimer's piracetam use in Alzheimer's piracetam induced changes in Alzheimer's piracetam effect on Alzheimer's piracetam reverses hippocampal changes in Alzheimer's piracetam and Alzheimer's disease piracetam controlled study on dementia piracetam effect on senile dementia memory Alcoholism piracetam in acute alcohol withdrawal piracetam alcoholic treatment piracetam efficacy in chronic alcoholics piracetam effect on alcoholics Child birth piracetam in parturients and newborn infants piracetam reduced duration of labor piracetam protective effect during delivery piracetam concentrations during delivery Circulatory Disorders piracetam effectiveness in cerebral arteriosclerosis piracetam and chronic cerebrovascular disorders piracetam effect on brain circulation failure Dyslexia piracetam learning aid in dyslexia piracetam in children with dyslexia piracetam in students with dyslexia piracetam efficacy in dyslexic reading and writing disorders piracetam verbal effect in dyslexic boys piracetam improves reading in dyslexia

66. JAMA -- Sign In Page Second, we concluded that migraine may increase the risk for silent brain patients with (sporadic) attacks of basilar migraine are at higher risk of http://jama.ama-assn.org/cgi/content/full/291/17/2072-a

Select Journal or Resource JAMA Archives of Dermatology Facial Plastic Surgery Family Medicine (1992-2000) General Psychiatry Internal Medicine Neurology Ophthalmology Surgery Student JAMA (1998-2004) JAMA CareerNet For The Media Meetings Peer Review Congress This item is restricted. Please see below for access options. Full Text Kruit et al. JAMA. To view this item, select one of the options below: Sign In User Name Subscribers, activate your online access. Help with Cookies. Can't get past this page? Password Forgot your user name or password? Purchase One-time Access Purchase Article - You may access and print this article (from the computer you are currently using) for 24 hours for US $12, plus applicable local tax. Purchase Access -You may access and print articles in JAMA Archives Journals (from the computer you are currently using) for 24 hours for US $30, plus applicable local tax. Regain Access - If you have previously used Purchase Article or Purchase Access and your access period has not yet expired, you may regain access using the user name and password you created at the time of purchase. Sign Up Activate - Subscribers and AMA Members, activate your online subscription for immediate full text access.

67. Neurology: Basilar Migraine: A Treatment Challenge She s recently been diagnosed with basilar vascular migraine accompanied bydizziness, Treating basilar and hemiplegic migraine is a special challenge. http://www.parkhurstexchange.com/qa/A.php?q=/qa/Neurology/2002-07-17.qa

68. Ivanhoe's Medical Breakthroughs - Discussion Groups They called it basilar migraine, and only finger pressure over places 3 fromboth sides will make tension, and basilar migraine headache stop completelly http://www.ivanhoe.com/discussion/p_discussion.cfm?forumid=9&messageID=35022&act

69. Virtual Hospital: PTNews therapy or for the treatment of hemiplegic or basilar migraine. Other 5HT1Bagonist use within 24 hours; Hemiplegic or basilar migraine http://www.vh.org/adult/provider/pharmacyservices/PTNews/1998/11PTN.html

Pharmacologic Management Of Migraines: Intranasal Treatment Options Brian McAfee, Pharm.D. Peer Review Status: Internally Peer Reviewed by Sue Barcellos, M.D., Assistant Professor, Director of the Headache Clinic, Department of Neurology Migraine is a common medical condition characterized by episodic, pulsating, unilateral headaches of moderate to severe intensity (inhibits or prohibits daily activity) that are aggravated by simple activity. Additional symptoms include nausea, with or without vomiting, and photophobia with phonophobia. Criteria for the diagnosis of migraine have been developed by the International Headache Society (see Table 1).1 It is estimated that as many as 23 million Americans suffer from migraines;2 the prevalence may exceed 10% of the U.S. population, and the condition is three to four times more likely to occur in women than in men.3 Migraines significantly affect the patient's quality of life, decrease worker productivity, and utilize significant healthcare resources. In addition to direct costs for medications, office visits, emergency room visits, healthcare provider services, and other medical treatment costs, the indirect costs of migraines have a tremendous economic impact. In 1992, the indirect costs associated with migraines were estimated to be between $1.4 and $17.2 billion per year. 4 The management of migraines has concentrated on preventing attacks, and when they do occur, effectively aborting the attacks. Abortive agents have focused on action at the serotonin 5-HT

70. International League Against Epilepsy Panayiotopoulos questioned the diagnosis of basilar migraine and reported 4 However, this case is often erroneously cited as “basilar migraine with http://www.ilae-epilepsy.org/Visitors/Centre/ctf/late_onset_idio_child_occ.cfm

Late Onset Childhood Occipital Epilepsy by C.P. Panayiotopoulos Date of submission: October 1, 1993 Date of update: October 14, 1998 Date of update: October 11, 1999 Date of update: October 26, 2000 Date of update: November 2, 2002 Date of update: October 3, 2003 Medline SEARCH DATE: October 2, 2003 Acknowledgements and disclosures Please disclose any financial or other conflicts of interest that might bias your contributions, or give rise to the perception of such bias. Relevant financial ties can include consultantships, memberships in speaker's bureaus, grants, research support, salaries, royalties, ownership, equity positions, stock options, or other financial arrangements wherein you stand to gain substantially from an increase of stock value or corporate revenues. Disclosures and acknowledgements will be linked to the author name(s) and will display along with appointments and affiliations. Disclosures, acknowledgements, and affiliations can be entered and updated via the "Update My Profile" link in the Online Submission System. Alternatively, you may send such information along with your updated manuscript. Thumbnail So that MedLink Corporation can highlight your clinical summary and your authorship on the MedLink Neurology home page and in our weekly email to subscribers, we ask that you provide here a brief overview of your subject (about 50 to 100 words) aimed at enticing readers to view this clinical summary.

71. Cleveland Clinic > Neuroscience > Stillman CV Stillman M, Oas J, Cherian N, FouadTerazi F Orthostatic intolerance and basilarmigraine the postural orthostatic tachycardia-basilar migraine syndrome. http://www.clevelandclinic.org/neuroscience/directory/stillmanCV.htm

Contact Us Appointments What We Treat About Us ... Stroke and Neurocritical Care Physician Directory MARK J. STILLMAN, M.D. Training and Education Professional/Academic Appointments Honors and Awards Licensure and Certificates ... Bibliography TRAINING AND EDUCATION 1972 - 1974 Bachelor of Science Degree Northwestern University Evanston, Illinois 1974 - 1978 M.D. Honors Program in Medicine Northwestern University Medical School Chicago, Illinois 1978 - 1981 Medical Internship and Residency University of Cincinnati Medical Center Cincinnati, Ohio 1981 - 1984 Neurology Residency Longwood Area Neurological Training Program Harvard Medical School Boston, Massachusetts 1984 - 1985 Neuro-oncology Fellowship Department of Neurology Memorial Sloan-Kettering Cancer Center New York, New York

72. RxMed: Pharmaceutical Information - IMITREX of migraine, or for the management of hemiplegic or basilar migraine. is contraindicated in patients with hemiplegic migraine, basilar migraine and http://www.rxmed.com/b.main/b2.pharmaceutical/b2.1.monographs/CPS- Monographs/CP

IMITREX® Injection/Tablets IMITREX® Nasal Spray Glaxo Wellcome Sumatriptan Succinate Sumatriptan Migraine Therapy Action And Clinical Pharmacology: Sumatriptan has been shown to be effective in relieving migraine headache. It is an agonist for a vascular 5-hydroxytryptamine1D (5-HT1D) receptor subtype (a member of the 5-HT1 family), and has only weak affinity for 5-HT1A receptors and no significant activity (as measured using standard radioligand binding assays) or pharmacological activity at 5-HT2, 5-HT3, 5-HT4, 5-HT5A, or 5-HT7 receptor subtypes, or at alpha1-, alpha2-, or beta-adrenergic; dopamine1 or dopamine2; muscarinic; or benzodiazepine receptors. Sumatriptan activates the 5-HT1D receptor subtype which is present on cranial arteries, on the basilar artery and in the vasculature of dura matter. This action correlates with relief of headache. The antimigrainous effect of sumatriptan is believed to be due to vasoconstriction of cranial arteries, which are dilated and edematous during a migraine attack. Experimental data from animal studies shows that sumatriptan also activates 5-HT1 receptors on peripheral terminals of the trigeminal nerve which innervates cranial blood vessels. This causes the inhibition of neuropeptide release. It is thought that such an action may contribute to the anti-migraine action of sumatriptan in humans.

73. Vernalis US Licensing Partner, Endo Pharmaceuticals Inc. Launches of migraine or for use in the management of hemiplegic or basilar migraine . have hemiplegic or basilar migraine, have had a stroke, have blood flow http://www.prnewswire.co.uk/cgi/news/release?id=143816

74. Case Histories - June #6 This update is for my mom who has basilar migraines. Hi I am a 54 year old femalewho was just diagnosed with basilar migraines. Here are my symptoms. http://www.migrainepage.com/journal/histfm.html

wiccanman4@aol.com chicago, il USA - Wed Jun 10 12:36:16 1998 Petercheri@aol.com Sacramento, CA USA - Tue Jun 9 23:59:53 1998 I AM A 35 YEAR OLD MALE WITH A THREE MONTH HEADACHE IN THE TOP OF MY HEAD WITH BRINGS ON MIGRAINES. I HAVE MISSED 2 AND 1/2 MONTHS WORK . NEO JUST GAVE UP.GOT TO FIND A GOOD ONE IN ARKANSAS. IF YOU KNOW OF ONE EMAIL ME AT SWANKY1@prodigy.net DANIEL SHELMAN MALVERN, AR USA - Tue Jun 9 22:30:54 1998 HAVE HAD MIGRAINES SINCE ABOUT THE AGE OF 5 AM 40 NOW WOW I REMEMBER THEY WOULD ALWAYS SEEM TO RUIN THE FAMILY PLANS FOR TRIPS VACATIONS AND OTHER FUN ACTIVITIES. I GET ABOUT 3 OR 4 SEVERE HEADACHES NOW PER WEEK. BEFOR THE LATEST DRUGS I LIVED OFF OF EXEDRIN FOR MANY MANY YEARS TAKING UP TO 22 IN ONE DAY JUST TO RELEIVE PAIN. IT SEEMS LIKE LATELY IVE TRIED JSUT ABOUT EVERYTHING. IMETRIX INJECTIONS WAS THE WONDER DRUG FOR ME. BUT IT SEEMS THAT AFTER 6HRS THE HEADACHE COMES BACK. I LIVE OFF IMITREX PILLS NASAL SPRAY AND INJECTIONS THE THING IS MY INSURANCE LIMITS MY PRESCRIPTIONS AND SUBJECTED TO TAKING MEDICATION WISELY. IVE HAD SEVERAL BRAIN SCANS AND THEY FOUND NO APEARANT PROBLEMS BEEN TO CHIROPRACTORS SPECIALIST AND QUACKS AND THEY FOUND NOTHING. ANYBODY KNOW A GOOD PREVENTIVE MEDICINE THAT HELPS CONTROL HEADACHES ITS KILLING ME WELL THATS MY STORY EJVILLA@PACBELL CA USA - Tue Jun 9 21:26:10 1998 mopar34069@aol.com

75. American Pain Foundation Hi, I take Topamax 200 mg a day for basilar migraines.Of all the meds I have been I took Topamax for several months for Basilar Artery Migraines (BAM). http://painaid.painfoundation.org/board/index.php?action=vthread&forum=6&topic=4

76. Newer Intranasal Migraine Medications - January 1, 2000 - American Academy Of Fa severe hepatic or renal disease, ongoing hemiplegic or basilar migraine, It is also contraindicated in patients with hemiplegic or basilar migraine, http://www.aafp.org/afp/20000101/180.html

Advanced Search AAFP Home Page Journals Vol. 61/No. 1 (January 1, 2000) Newer Intranasal Migraine Medications CRAIG D. LOGEMANN, PHARM.D. Iowa Lutheran Hospital Family Practice Residency, Des Moines, Iowa LYNN M. RANKIN, M.D. Integra Health Medical Foundation, Des Moines, Iowa Two new intranasal migraine medications, sumatriptan and dihydroergotamine mesylate, may offer specific advantages for patients who are seeking alternatives to various oral or parenteral migraine abortive therapies. Placebo-controlled clinical studies demonstrate that both intranasal forms are effective in relieving migraine headache pain, but published clinical trial information comparing these two intranasal medications with current abortive therapies is lacking. Both agents are generally well tolerated by patients, with the exception of mild, local adverse reactions of the nose and throat. (Am Fam Physician 2000;61:180-6.) M igraine headaches are fairly common in the general population: 17.6 percent of women and 5.7 percent of men have one or more migraine headaches per year. Because of the episodic nature of migraine attacks, treatment options that rapidly and effectively minimize pain are needed. Although nonpharmacologic interventions play a role in headache management, most migraine patients seek relief with medication. Approximately 95 percent of patients with severe migraine take some medication (prescription or over-the-counter) for their headaches.

77. ZOMIG NASAL SPRAY: Prescribing Considerations ZOMIG should not be administered to patients with hemiplegic or basilar migraine., ZOMIG should not be given to patients with ischemic heart disease http://www.zomig.com/professional_html/details/considerations.asp

E-Mail This Site to a Colleague Contact Us Bookmark This Site Indications ZOMIG (zolmitriptan) is indicated for the acute treatment of migraine with or without aura in adults ZOMIG is not intended for the prophylactic therapy of migraine. Safety and effectiveness of ZOMIG have not been established for cluster headache, which is present in an older, predominantly male population Contraindications and warnings ZOMIG should not be administered to patients with hemiplegic or basilar migraine ZOMIG should not be given to patients with ischemic heart disease (angina pectoris, history of myocardial infarction, or documented silent ischemia), or to patients who have symptoms or findings consistent with ischemic heart disease, coronary artery vasospasm, including Prinzmetal's variant angina, or other significant underlying cardiovascular disease Because ZOMIG may increase blood pressure, it should not be given to patients with uncontrolled hypertension It is strongly recommended that ZOMIG not be given to patients in whom unrecognized CAD is predicted by the presence of risk factors (e.g., hypertension, hypercholesterolemia, smoking, obesity, diabetes, strong family history of CAD, women with surgical or physiological menopause, or men over 40 years of age) unless a cardiovascular evaluation provides satisfactory clinical evidence that the patient is reasonably free of coronary artery and ischemic myocardial disease or other significant underlying cardiovascular disease

78. ZOMIG NASAL SPRAY: FAQ therapy of migraine or for use in management of hemiplegic or basilar migraine . not be administered to patients with hemiplegic or basilar migraine. http://www.zomig.com/consumer_html/details/faq.asp

E-mail This Site to a Friend Contact Us Bookmark This Site When were ZOMIG Nasal Spray, ZOMIG-ZMT ... What are the most common side effects that are experienced by patients taking ZOMIG Nasal Spray, ZOMIG-ZMT, and ZOMIG Tablets? When were ZOMIG Nasal Spray, ZOMIG-ZMT (zolmitriptan) Orally Disintegrating Tablets and ZOMIG (zolmitriptan) Tablets released? In October of 1997, ZOMIG 2.5 mg and 5 mg tablets were approved for marketing by the US Food and Drug Administration (FDA). ZOMIG-ZMT 2.5-mg tablets received FDA approval in February of 2001. ZOMIG-ZMT 5-mg tablets received FDA approval in September of 2001. ZOMIG Nasal Spray received FDA approval in September of 2003. Back to Top Is ZOMIG Nasal Spray, ZOMIG-ZMT, or ZOMIG Tablets available as a generic? No. ZOMIG was first approved for acute treatment of migraine in 1997. Because the drug is still on patent, there are no generic forms available. Back to Top What is the indication for ZOMIG Nasal Spray, ZOMIG-ZMT and ZOMIG Tablets? ZOMIG Nasal Spray, ZOMIG-ZMT, and ZOMIG Tablets are indicated for the acute treatment of migraine with or without aura in adults. ZOMIG Nasal Spray, ZOMIG-ZMT, and ZOMIG are not intended for the prophylactic therapy of migraine or for use in management of hemiplegic or basilar migraine. Safety and effectiveness of ZOMIG Nasal Spray, ZOMIG-ZMT, and ZOMIG Tablets have not been established for cluster headache.

79. The Ridgeway Surgery; Dizzy Attack The headache is throbbing and is of a migrainous type. This syndrome is calledbasilar migraine and responds to conventional migraine treatment. http://www.ridgeway-surgery.demon.co.uk/acute/dizzy.htm

Doctor I feel dizzy Introduction Dizziness is a difficult symptom. It is a term used by patients to describe a feeling alien to them for which they cannot find a more exact description. The doctors first job is to clarify what the patient means by dizziness. Have a look through these questions. Do you feel as if you are spinning? Most patients with a true vertigo immediately recognise this is what they mean. However, some patients may need clarification - for example comparing the feeling to getting off a roundabout or merry-go-round, or if you stop suddenly after spinning round and round. If this is the sensation is it continuous or intermittent? Intermittent vertigo: Is it associated with nausea and vomiting? Do any activities make it worse? Is there any relationship to movement. Do you have any problems with your hearing? Do you get a headache after the dizziness? Patients with a clear history of positionally related vertigo almost always have benign positional vertigo. The vertigo is brief (less than one minute), triggered by movement, reduces with repeated movement and is usually associated with nausea or, if severe, occasionally vomiting. In some patients this syndrome can follow head injury. Examination is normal with the exception of Hallpike's manoeuvre (see below). This syndrome is usually easily recognisable and your doctor can make a confident diagnosis on clinical findings alone. If a patient has had previous attacks of vertigo, has associated ringing in the ears (tinnitus) and one-sided deafness a diagnosis of Meniere's disease is suggested. This is however rare and requires more formal assessment. An audiogram hearing test will show a characteristic loss of high tone hearing. This diagnosis is made with less certainty and there is no specific diagnostic test. This is an overdiagnosed condition.

80. Late Onset Childhood Occipital Epilepsy Camfield PR, Metrakos K, Andermann F. basilar migraine, seizures, basilar migraine?Seizures, and severe epileptic EEG abnormalities. http://www.epilepsy.org/ctf/late_onset_idio_child_occ.html

Late Onset Childhood Occipital Epilepsy by C.P. Panayiotopoulos Date of submission: October 1, 1993 Date of update: October 14, 1998 Date of update: October 11, 1999 Date of update: October 26, 2000 Date of update: November 2, 2002 Date of update: October 3, 2003 Medline SEARCH DATE: October 2, 2003 Acknowledgements and disclosures Please disclose any financial or other conflicts of interest that might bias your contributions, or give rise to the perception of such bias. Relevant financial ties can include consultantships, memberships in speaker's bureaus, grants, research support, salaries, royalties, ownership, equity positions, stock options, or other financial arrangements wherein you stand to gain substantially from an increase of stock value or corporate revenues. Disclosures and acknowledgements will be linked to the author name(s) and will display along with appointments and affiliations. Disclosures, acknowledgements, and affiliations can be entered and updated via the "Update My Profile" link in the Online Submission System. Alternatively, you may send such information along with your updated manuscript. Thumbnail So that MedLink Corporation can highlight your clinical summary and your authorship on the MedLink Neurology home page and in our weekly email to subscribers, we ask that you provide here a brief overview of your subject (about 50 to 100 words) aimed at enticing readers to view this clinical summary.

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 4     61-80 of 92    Back | 1  | 2  | 3  | 4  | 5  | Next 20